Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
PARAPHARM PLUS from Kortrijk, company number BE0454447473, closed financial year 2025 with a result of € -2,951 after tax. For that financial year PARAPHARM PLUS recorded a gross margin of € -1,794 and equity of € -395,554. Compared with financial year 2024, the result moved from € -2,703 to € -2,951. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2026.
€ -395,554
▼ € 2,951 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,951
▼ 9 % more loss than in 2024
Profit after tax over the fiscal year.
€ 449
▼ 67% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -519,501.
Debts at end 2025
€ 1.4 million
Loans from banks and other lenders, long and short.
€ 59
▼ 76% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -635 | € -836 | € -1,581 | € -1,794 | ▼ € 213 |
| Profit after taxes | € 9,629 | € -121,590 | € -2,703 | € -2,951 | ▼ € 247 |
| Equity | € -268,310 | € -389,901 | € -392,604 | € -395,554 | ▼ € 2,951 |
| Total debts | € 1,381,763 | € 1,384,151 | € 1,387,132 | € 1,389,344 | |
| Cash | € 610 | € 1,064 | € 1,341 | € 449 | ▼ 67% |
| Retained profit | € -392,257 | € -513,847 | € -516,551 | € -519,501 | ▼ € 2,951 |
| Bank debt | € 0 | € 0 | € 0 | € 1,389,285 | |
| Balance sheet total | € 1,113,452 | € 994,251 | € 994,528 | € 993,790 |
Key figures of PARAPHARM PLUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PARAPHARM PLUS?
What happened at PARAPHARM PLUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- PODELMO BV stepped down as director. NBB
- Etienne Declercq stepped down as director. NBB
- DAMIER stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2,951. Source: NBB ↗
- PODELMO BV became a director. NBB
- Etienne Declercq became a director. NBB
- DAMIER became a director. NBB
- New establishment in Kortrijk. KBO
In short
From € 9,629 profit in 2022 to € 2,951 loss in 2025.
Best year ever: 2022, with € 9,629 profit.
A new publication or filing at PARAPHARM PLUS? We notify you, reason included.
Follow PARAPHARM PLUSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of RENT-ESTATE, DAMIER comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PARAPHARM PLUSThe shares are held by RENT-ESTATE (40%) and DAMIER (20%). It owns 26.7% of VILLA EMMA and 26.5% of DC 3 itself.
Directors
According to the 2025 annual accounts
since 2025 · until 2031
Etienne Declercq
Director
since 2025 · until 2031
Managing director · represented by Vindevogel Yvan
Also active at: THE ARK, Vision HC, VHC INVESTCO, CARE INVESTCO, PK Investco
since 2025 · until 2031
Shareholders
40%
20%
Participations
26.7%
26.5%
Establishments
Establishment units
Physical locations of this company
Koning Leopold I-straat(Kor) 22
8500 Kortrijk
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0454.447.473
- VAT number
- BE 0454.447.473
- Registered office
- Koning Leopold I-straat(Kor) 22, 8500 Kortrijk
- Names & denominations
- PARAPHARM PLUS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 February 1995
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van holdings
Holdings